Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
DESCRIPTION The global regenerative drugs market is expected to grow at a CAGR of XX.XX% to reach a total market size of US$XX.XX billion by 2023, increasing from US$XX.XX billion in 2018. Regenerative drugs or medicines are used to heal body tissues or organs from within. The process is called rejuvenation in which these medicines repair the damaged body organs which otherwise cannot heal naturally. Regenerative medicines also help in replacement where healthy cells, tissues or organs are used from a dead or healthy donor to replace damaged cells, tissues or organs. The other way to heal a damaged tissue by these medicines is by delivering healthy cells or tissues to diseased or damaged cells in order to retain body’s normal functioning which is known as regeneration. Regenerative drugs also increase the possibility of growing organs in the lab conditions, where cells from the patient’s own body can be used for regeneration which can reduce the chances of organ transplant rejection. Companies like Baxter International, Stryker Corporation, Medtronic plc., Cryolife, Inc., and Organogenesis, Inc (Advanced Biohealing) are among the major key players of global regenerative drugs market. By Type On the basis of types, global regenerative drugs market is segmented as synthetic, biologically derived and genetically derived. By Materials On the basis of materials, global regenerative drugs market is segmented as biodegradable synthetic polymers, scaffold, hydrogel & collagen, transgenic and fibroblasts. By Application
Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
On the basis of application, global regenerative drugs market is segmented as cardiovascular,
oncology,
dermatology,
musculoskeletal,
wound
healing,
ophthalmology, neurology and others. By End-Users End users of global regenerative drugs market include hospitals, biomedical laboratories and research centres. By Geography Geographically, global regenerative drugs market is segmented as North America, South America, Europe, Middle East and Asia Pacific region.Germany, France and UK are the major hubs which have a significant European commercial sector for regenerative medicines. These include mostly cell-based therapies from patient’s own body and also from the unrelated donors.
Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
TABLE OF CONTENTS 1. Introduction 1.1. Market Definition 1.2. Scope of the Study 1.3. Currency 1.4. Assumptions 1.5. Base, and Forecast Years Timeline 2. Research Methodology 2.1. Research Design 2.2. Secondary Sources 2.3. Validation 3. Key Findings of the Study 4. Market Dynamics 4.1. Drivers 4.2. Restraints 4.3. Opportunities and Market Trends 4.4. Market Segmentation 4.5. Porter’s Five Forces Analysis 4.5.1. Bargaining Power of Suppliers 4.5.2. Bargaining Power of Buyers 4.5.3. Threat of New Entrants 4.5.4. Threat of Substitutes 4.5.5. Competitive Rivalry in the Industry 4.6. Industry Value Chain Analysis 4.7. Industry Regulations 5. Global Regenerative Drugs Market Forecast by Type (US$ Billion) 5.1. Introduction Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
5.2. Synthetic 5.3. Biologically Derived 5.4. Genetically Derived 6. Global Regenerative Drugs Market Forecast by Technology (US$ Billion) 6.1. Introduction 6.2. Stem cell Therapy 6.3. Gene Therapy 6.4. Tissue Engineering 6.5. Small Molecules & Biologics 7. Global Regenerative Drugs Market Forecast by Materials (US$ Billion) 7.1. Introduction 7.2. Biodegradable Synthetic Polymers 7.3. Scaffold 7.4. Hydrogel & Collagen 7.5. Transgenic 7.6. Fibroblasts 8. Global Regenerative Drugs Market Forecast by Applications (US$ Billion) 8.1. Introduction 8.2. Cardiovascular 8.3. Oncology 8.4. Dermatology 8.5. Musculoskeletal 8.6. Wound Healing 8.7. Ophthalmology 8.8. Neurology 8.9. Others 9. Global Regenerative Drugs Market Forecast by End-Users (US$ Billion) 9.1. Hospitals 9.2. Biomedical Laboratories 9.3. Research Centers 10. Global Regenerative Drugs Market Forecast by Geography (US$ Billion) 10.1. Introduction Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
10.2. North America 10.3. South America 10.4. Europe 10.5. Middle East and Africa (MEA) 10.6. Asia Pacific (APAC) 11. Competitive Intelligence 11.1. Market Share Analysis 11.2. Strategies of Key Players 11.3. Recent Investments and Deals 12. Company Profiles 12.1. Baxter International 12.1.1. Overview 12.1.2. Financials 12.1.3. Products and Services 12.1.4. Key Developments 12.2. Stryker Corporation 12.2.1. Overview 12.2.2. Financials 12.2.3. Products and Services 12.2.4. Key Developments 12.3. Medtronic plc. 12.3.1. Overview 12.3.2. Financials 12.3.3. Products and Services 12.3.4. Key Developments 12.4. Cryolife, Inc. 12.4.1. Overview 12.4.2. Financials 12.4.3. Products and Services 12.4.4. Key Developments 12.5. Organogenesis, Inc (Advanced Biohealing) 12.5.1. Overview Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
12.5.2. Financials 12.5.3. Products and Services 12.5.4. Key Developments List of Tables List of Figures
Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023
TO ORDER OR REQUEST FOR A SAMPLE: Product: Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023 Link:https://www.knowledge-sourcing.com/products/global-regenerative-drugs-marketindustry-trends-opportunities-and-forecasts-to-2023 Price: US$3,600 – Single User License US$4,600 – Multi User License US$6,600 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment For wire transfer, write to us at sales@knowledge-sourcing.com
For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-866-714-4587
Global Regenerative Drugs Market - Industry Trends, Opportunities and Forecasts to 2023